Package 59922-641-60

{"route": ["ORAL"], "spl_id": "86ed554e-938d-4f6a-abba-672284f21ca5", "openfda": {"nui": ["N0000194080", "N0000194079", "N0000190113", "N0000190111"], "upc": ["0359922643605", "0359922642608", "0359922641601"], "unii": ["I60W9520VV"], "rxcui": ["2679301", "2679307", "2679309", "2679311", "2679313", "2679315"], "spl_set_id": ["ac9da724-5a62-4ab6-a89c-376a25f6195b"], "pharm_class_epc": ["Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]"], "pharm_class_moa": ["Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Organic Anion Transporter 3 Inhibitors [MoA]"], "manufacturer_name": ["Akebia Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (59922-641-60)  / 60 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "59922-641-60", "marketing_start_date": "20240328"}], "brand_name": "VAFSEO", "product_id": "59922-641_86ed554e-938d-4f6a-abba-672284f21ca5", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]", "Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]", "Organic Anion Transporter 3 Inhibitors [MoA]"], "product_ndc": "59922-641", "generic_name": "Vadadustat", "labeler_name": "Akebia Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VAFSEO", "active_ingredients": [{"name": "VADADUSTAT", "strength": "150 mg/1"}], "application_number": "NDA215192", "marketing_category": "NDA", "marketing_start_date": "20240328", "listing_expiration_date": "20261231"}